Incyte (INCY) Misses Q4 EPS by 76c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Incyte (INCY) PT Lowered to $87 at RBC Capital, 'Buyers on Weakness'
February 8, 2022 3:54 PM ESTRBC Capital analyst Brian Abrahams lowered the price target on Incyte (NASDAQ: INCY) to $87.00 (from $90.00) while maintaining an Outperform rating and said they would buy on weakness.
The analyst commented, "4Q featured strong initial launch metrics for Opzelura, solid sales for INCY's core MF... More
Mizuho Securities Reiterates Neutral Rating on Incyte (INCY)
February 8, 2022 7:53 AM ESTMizuho Securities analyst Mara Goldstein reiterated a Neutral rating and $95.00 price target on Incyte (NASDAQ: INCY) following the company's recent earnings report.
For an analyst ratings summary and ratings history on Incyte click here. For more ratings news on Incyte click here.
Shares of Incyte closed at $73.35 yesterday.
... More